Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational Study.
Khalid Al SulaimanMashael Al MutairiOmar Al HarbiAlanoud Al DuraihimSara AldosaryHaifa Al KhalilAbdulrahman Al ShayaShmeylan Al HarbiNouf E AlotaibiKholoud Al AamerRamesh VishwakarmaMohammed Al AsiriOhoud AljuhaniAbdulmalik Al KatheriAbdulkareem M Al BekairyPublished in: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2022)
The administration of vitamin K for INR correction in critically ill patients with coagulopathy secondary to liver disease was not associated with a lower odds of new bleeding events. Further studies are needed to assess the value of vitamin K administration in critically ill patients with liver diseases related coagulopathy.
Keyphrases